Formulary Monographs [DAUNORUBICIN, 1000]
|
|
DAUNORUBICIN
|
|
|
|
|
|
ANTINEOPLASTICS
|
|
|
Induction of remission of acute leukaemias.
|
|
|
Dose related myelosuppression, cardiotoxicity, alopecia, urine discoloration; extravasation.
|
|
|
40 - 60 mg/m2 on alternate days for a course of up to 3 injections.
|
|
|
|
|
|
Daunorubicin may cause fetal harm when administered to a pregnant woman. Animal studies have shown an increased incidence in fetal abnormalties
|
|
|
Discontinue breastfeeding.
|
|
|
|